Sumimasa Nagai

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Transcription Factor

Chronic Lymphocytic Leukemia

Radical Prostatectomy

Top Venues

Clinical pharmacology and therapeutics

International journal of molecular sciences

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Kensuke Matsuda, Sumimasa Nagai, Koichi Sugimoto
Characteristics of Drugs from Non-Global Companies for Hematologic Malignancies and Impact on Global Regulatory Approval. Clinical pharmacology and therapeutics (2024)
Sumimasa Nagai, Hiroshi Nishihara, Takayoshi Suzuki, Kazuto Nishio, Hiroya Taniguchi, Katsuya Tsuchihara, Kohei Nakamura, Reika Takamatsu, Toshihide Ueno, Hiroyuki Aburatani, Takashi Kohno, Shinji Kohsaka
Recommendations related to the analytical equivalence assessment of gene panel testing. Cancer science 113 (10) (2022)
Sumimasa Nagai
Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan. International journal of molecular sciences 20 (15) (2019)
Sumimasa Nagai, Keiya Ozawa
Drug approval based on randomized phase 3 trials for relapsed malignancy: analysis of oncologic drugs granted accelerated approval, publications and clinical trial databases. Investigational new drugs 36 (3) (2018)